Last 466.20 INR
Change Today 0.00 / 0.00%
Volume 0.0
STR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

strides arcolab ltd (STR) Snapshot

Open
458.05
Previous Close
460.15
Day High
469.80
Day Low
451.00
52 Week High
04/7/14 - 488.00
52 Week Low
08/1/13 - 239.40
Market Cap
27.8B
Average Volume 10 Days
667.3K
EPS TTM
144.30
Shares Outstanding
59.6M
EX-Date
12/19/13
P/E TM
3.2x
Dividend
--
Dividend Yield
107.68%
Current Stock Chart for STRIDES ARCOLAB LTD (STR)

Related News

No related news articles were found.

strides arcolab ltd (STR) Related Businessweek News

View More BusinessWeek News

strides arcolab ltd (STR) Details

Strides Arcolab Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical products in India and internationally. The company offers a portfolio of specialty pharmaceutical products in various categories, including penems, penicillins, cephalosporins, ophthalmics, peptides, controlled substances, and oncology drugs and other high potency drugs in a range of packaging formats comprising vials, pre filled syringes, suspension injections, ampoules, and lyophilized forms. It also provides nutraceuticals and Rx soft gelatine capsules, immunosuppressants, anti-retorvirals, anti-Tb and anti-malarial drugs, and oral solids in various therapies. In addition, the company provides branded generic products in antibiotics, anti-diabetics, anti-hypertensives/cardiac, pulmocare, gastro, gynae care, herbal, NSAID and ortho, health and nutritional supplements, and other segments; and oncology, nephrology, critical care. Further, it offers branded generics, commodity generics, and over the-counter products in various dosage forms, such as oral solids, semisolids, oral liquids, and injectables. The company was formerly known as Strides Pharmaceuticals Private Limited and changed its name to Strides Arcolab Limited in 1996. Strides Arcolab Limited was founded in 1990 and is headquartered in Bengaluru, India.

2,700 Employees
Last Reported Date: 05/18/13
Founded in 1990

strides arcolab ltd (STR) Top Compensated Officers

Founder, Executive Vice Chairman, Managing Di...
Total Annual Compensation: 40.0M
Chief Executive Officer of Agila Specialities
Total Annual Compensation: 12.7M
Compensation as of Fiscal Year 2012.

strides arcolab ltd (STR) Key Developments

Strides Arcolab Ltd Appoints Sangita Reddy as Director

Strides Arcolab Ltd. announced that Ms. Sangita Reddy has on February 07, 2014, joined the Board of the company as an Independent Director. Sangita is executive director of Apollo Hospitals Group.

Strides Arcolab Ltd. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013

Strides Arcolab Ltd. announced unaudited earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported net sales of INR 2,402.433 million compared with INR 1,520.906 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 179.397 million compared with INR 29.355 million for the same period a year ago. Profit from ordinary activities before tax was INR 46,427.381 million compared with INR 778.307 million for the same period a year ago. Net profit was INR 35,252.413 million or INR 595.12 per diluted share compared with INR 739.307 million or INR 12.46 per diluted share for the same period a year ago. For the year, the company reported net sales of INR 7,515.973 million compared with INR 6,132.885 million for the same period a year ago. Profit from operation before other income, finance cost and exceptional items was INR 799.491 million compared with INR 766.071 million for the same period a year ago. Profit from ordinary activities before tax was INR 46,785.834 million compared with INR 598.859 million for the same period a year ago. Net profit was INR 35,611.865 million or INR 599.85 per diluted share compared with INR 559.859 million or INR 5.84 per diluted share for the same period a year ago.

Strides Arcolab Ltd., Q4 2013 Earnings Call, Feb 07, 2014

Strides Arcolab Ltd., Q4 2013 Earnings Call, Feb 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STR:IN 466.20 INR +6.05

STR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,175 GBp +132.50
Endo International PLC $61.70 USD -0.32
Johnson & Johnson $100.20 USD -0.02
Merck & Co Inc $57.72 USD +0.22
Pfizer Inc $30.70 USD -0.225
View Industry Companies
 

Industry Analysis

STR

Industry Average

Valuation STR Industry Range
Price/Earnings 3.1x
Price/Sales 1.1x
Price/Book 1.2x
Price/Cash Flow 2.6x
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRIDES ARCOLAB LTD, please visit www.stridesarco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.